Blueprint Medicines Corporation Financial Ratios — BPMC

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-149.04	-46.12	-31.4	-29.67	-37.69	-55.73	25.88	-43.36	-42.85	-42.26	-6.02
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	-45.13	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	29.03	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	100	100	99.95	90.04	91.27	96.58	96.04
EBITDA Margin (%)	- -	- -	-444.7	-255.64	-698.54	-545.32	-535.34	39.72	-348.57	-253.31	-188.61	-38.47
Operating Margin (%)	- -	- -	-453.02	-261.33	-705.9	-554.86	-543.25	38.89	-352.17	-259.06	-193.29	-41.67
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	92.14	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	-462.89	-261.04	-691.3	-531.53	-522.75	39.68	-356	-270.68	-202.91	-12.94
Profit Margin (%)	- -	- -	-462.89	-261.04	-691.3	-531.53	-522.75	39.54	-357.67	-273.24	-203.3	-13.19
Net Income to Common Margin (%)	- -	- -	-490.54	-261.04	-691.3	-531.53	-522.75	39.54	-357.67	-273.24	-203.3	-13.19
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	0.34	- -	- -	- -	- -
Dvd Payout Ratio (%)	12.07	12.52	5.64	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	3	9	11	7	18	15	96	90	111	242	332	469
ST Debt	1	2	4	3	3	2	7	8	8	27	42	57
LT Debt	2	7	7	4	15	13	89	82	103	215	290	412
Total Debt/EBITDA	-0.14	-0.23	-0.22	-0.1	-0.12	-0.06	-0.27	0.28	-0.18	-0.47	-0.71	-2.4
Net Debt/EBITDA	-0.04	0.98	3.06	0.68	2.66	0.28	0.32	-2.17	0.33	-0.04	-0.36	-1.46
Total Debt/EBIT	-0.14	-0.23	-0.22	-0.1	-0.12	-0.06	-0.27	0.29	-0.18	-0.46	-0.69	-2.21
Net Debt/EBIT	-0.04	0.96	3.01	0.66	2.64	0.28	0.32	-2.22	0.33	-0.04	-0.35	-1.34
EBITDA to Interest Expense	-148.54	-86.34	-72.84	-151.38	-677.24	-3,325.78	- -	- -	- -	- -	-9.11	-2.84
EBITDA-CapEx/Interest Expense	-150.41	-87.89	-79.85	-156.39	-747.43	-3,499.44	- -	- -	- -	- -	-9.43	-2.91
EBIT to Interest Expense	-152.17	-87.71	-74.2	-154.75	-684.38	-3,383.95	- -	- -	- -	- -	-9.34	-3.08
Interest Expense	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	52	69
Common Equity/Total Assets	-1,013.78	-164.65	-75.43	-73.35	-49.68	-110.62	-133.56	-36.74	-101.85	-135.78	-223.01	-204.01
Long-Term Debt/Equity (%)	- -	20.71	5.17	2.02	2.34	3.08	19.19	5.56	10.64	41.78	222.26	137.89
Long-Term Debt/Capital (%)	239.18	17.62	-6.02	-2.16	-4.33	-2.21	-10.49	-15.08	-8.88	-13.52	-14.46	-21.25
Long-Term Debt/Total Assets (%)	52.12	14.7	4.16	1.52	2.04	2.39	12.59	4.75	8.25	15.93	27.67	34.91
Total Debt/Equity (%)	-191.38	25.52	7.84	3.49	2.86	3.49	20.66	6.1	11.48	47.11	254.57	157.07
Total Debt/Capital (%)	317.76	21.71	-9.13	-3.72	-5.29	-2.51	-11.3	-16.54	-9.57	-15.24	-16.56	-24.21
Total Debt/Total Assets (%)	69.24	18.11	6.31	2.63	2.49	2.71	13.56	5.21	8.9	17.96	31.69	39.76
Net Debt to Equity	-58.56	-107.82	-107.91	-22.53	-63.91	-16.24	-24.54	-46.57	-21.63	3.76	128.27	95.41
Net Debt/Capital (%)	-80.66	683.21	54.25	19.04	54.04	10.46	11.83	55.83	15.28	-1.13	-8.06	-13.97
EBITDA	-20	-39	-51	-71	-150	-243	-356	315	-628	-517	-470	-196
EBITDA-CapEx	-21	-40	-56	-73	-165	-255	-370	312	-889	-526	-486	-200
Operating Income (Loss)	-21	-40	-52	-73	-151	-247	-361	309	-634	-529	-482	-212

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	0.63	6.98	8.73	7.51	15.7	8.19	4.54	6.67	3.19	5.16	3.31	2.36
Current Ratio	0.78	7.14	9.14	7.73	15.98	8.29	4.85	7.09	3.7	5.71	3.76	2.85
Quick Ratio	0.63	6.98	8.91	7.64	15.7	8.19	4.76	6.86	3.43	5.36	3.51	2.66
CFO/Avg Current Liab	- -	-7.14	-2.49	-1.04	-3.36	-3.39	-3.33	3.26	-2.13	-3.02	-2.19	-0.81
Common Equity/Total Assets	-1,013.78	-164.65	-75.43	-73.35	-49.68	-110.62	-133.56	-36.74	-101.85	-135.78	-223.01	-204.01
Long-Term Debt/Equity (%)	- -	20.71	5.17	2.02	2.34	3.08	19.19	5.56	10.64	41.78	222.26	137.89
Long-Term Debt/Capital (%)	239.18	17.62	-6.02	-2.16	-4.33	-2.21	-10.49	-15.08	-8.88	-13.52	-14.46	-21.25
Long-Term Debt/Total Assets (%)	52.12	14.7	4.16	1.52	2.04	2.39	12.59	4.75	8.25	15.93	27.67	34.91
Total Debt/Equity (%)	-191.38	25.52	7.84	3.49	2.86	3.49	20.66	6.1	11.48	47.11	254.57	157.07
Total Debt/Capital (%)	317.76	21.71	-9.13	-3.72	-5.29	-2.51	-11.3	-16.54	-9.57	-15.24	-16.56	-24.21
Total Debt/Total Assets (%)	69.24	18.11	6.31	2.63	2.49	2.71	13.56	5.21	8.9	17.96	31.69	39.76
CFO/Total Liabilities	-337.86	-244.21	-90.71	-35.16	-130.62	-144.5	-114.25	155.87	-106.1	-60.14	-47.55	-21.86
CFO/CapEx	-74.03	-50.57	-6.49	-10.41	-7.73	-13.81	-19.84	122.52	-1.14	-56.32	-27.2	-41.6
Altman's Z-Score	-31.16	-3.93	7.33	5.68	18.35	9.72	6.68	15.88	10.79	-0.4	-0.07	1.21

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	1,391.28	182.98	204.6	11.17	8.38	7.52	8.58
Days Sales Outstanding	- -	- -	- -	- -	- -	0.26	1.99	1.78	32.68	43.54	48.56	42.55
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	0.1	1.18	0.69	0.34	1.16
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	3,684.78	309.34	527.78	1,088.16	315.29
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	1.97	4.91	4.65	0.02	2.18
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	185.68	74.38	78.57	20,569.96	167.22
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	3,500.88	267.64	492.75	-19,433.24	190.62
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	-3,683	-276.65	-484.24	-1,039.6	-272.74
Inventories	- -	- -	- -	- -	- -	- -	- -	9	22	30	21	14
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	9	22	30	21	14

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	480	771	2,850	2,365	3,832	6,116	6,268	2,613	5,586	5,482
- Cash & Cash Equivalents	2	47	163	52	400	68	114	685	210	120	71	102
+ Preferred Equity and Hybrid Capital	40	115	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	9	11	7	18	15	96	90	111	242	332	469
Enterprise Value	41	77	329	564	2,194	1,885	3,444	5,334	5,902	1,910	5,208	5,336
Total Capital	1	42	-124	-200	-338	-583	-849	-542	-1,164	-1,590	-2,007	-1,938
Total Debt/Capital (%)	317.76	21.71	-9.13	-3.72	-5.29	-2.51	-11.3	-16.54	-9.57	-15.24	-16.56	-24.21
Total Debt / EV	0.07	0.12	0.03	0.01	0.01	0.01	0.03	0.02	0.02	0.13	0.06	0.09
EV/Sales	- -	- -	28.85	20.32	102.42	42.35	51.78	6.72	32.78	9.36	20.88	10.49
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	16.92	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	17.28	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	13.78	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	13.67	- -	- -	- -	- -
Diluted Market Cap	- -	- -	480	771	2,850	2,365	3,832	6,299	6,268	2,613	5,586	5,482
Diluted Enterprise Value	41	77	329	727	2,468	2,311	3,814	5,704	6,169	2,736	5,847	5,849
EV per Share	3.12	5.86	18.04	20.53	58.07	42.98	72.01	97.81	100.86	32.03	86	84.89
TTM Sales	- -	- -	11	28	21	45	67	794	180	204	249	509
TTM EBITDA	-20	-39	-51	-71	-150	-243	-356	315	-628	-517	-470	-196
TTM Operating Income	-21	-40	-52	-73	-151	-247	-361	309	-634	-529	-482	-212
TTM Cash Flow to Firm	-19	-35	-31	-24	-120	-175	-278	387	-299	-502	-385	-122
TTM Free Cash Flow to Firm	-19	-34	-26	-22	-104	-162	-264	390	-37	-493	-369	-118

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Free Cash Flow	- -	- -	-17.93	-34.8	-27.31	-14.57	-14.51	16.14	-167.54	-5.3	-13.27	-29.17
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	17.28	- -	- -	- -	- -
Enterprise Value	41	77	329	564	2,194	1,885	3,444	5,334	5,902	1,910	5,208	5,336
Low Price	- -	- -	18	13.04	27.83	44.58	48.28	43.29	79.08	40.78	37.82	72.24
EV/Sales	- -	- -	28.85	20.32	102.42	42.35	51.78	6.72	32.78	9.36	20.88	10.49
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	16.92	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	19.48	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-8.47	-8.59	-12.9	-13.71	-10.93	13.68	-8.84	-6.48	-6.5	-88.33
Price/Earnings High	- -	- -	-12.12	-14.54	-23.47	-20.21	-14.17	21.82	-10.71	-11.79	-11.23	-114.21
Price/Earnings Low	- -	- -	-5.87	-4.95	-7.1	-8.26	-6.64	7.52	-7.18	-4.36	-4.52	-67.68
Price/Book Value	- -	- -	-3.56	-3.72	-8.02	-3.96	-4.05	-9.69	-4.91	-1.43	-2.39	-2.28
Price/Book Value Average	- -	- -	-3.51	-3	-5.38	-5.43	-4.02	-6.8	-4.46	-1.97	-1.41	-2.46
Price/Book Value High	- -	- -	-5.02	-5.08	-9.78	-8	-5.21	-10.85	-5.41	-3.59	-2.43	-3.18
Price/Book Value Low	- -	- -	-2.43	-1.73	-2.96	-3.27	-2.44	-3.74	-3.63	-1.33	-0.98	-1.89
Price/Tangible Book Value	- -	- -	3.34	3.62	4.57	5.64	8.25	4.16	6.46	5.08	42.77	18.36
Price/Tangible Book Value Average	- -	- -	3.29	2.92	3.06	7.74	8.19	2.92	5.86	7.02	25.25	19.84
Price/Tangible Book Value High	- -	- -	4.71	4.95	5.57	11.41	10.61	4.66	7.1	12.77	43.58	25.66
Price/Tangible Book Value Low	- -	- -	2.28	1.68	1.69	4.67	4.97	1.61	4.77	4.73	17.54	15.2
Price/Sales	- -	- -	42.13	27.77	133.01	53.12	57.61	7.71	34.81	12.81	22.4	10.77
Price/Sales Average	- -	- -	41.53	22.43	89.21	72.85	57.16	5.41	31.62	17.72	13.22	11.65
Price/Sales High	- -	- -	59.46	37.94	162.28	107.4	74.05	8.63	38.3	32.22	22.83	15.06
Price/Sales Low	- -	- -	28.79	12.91	49.09	43.92	34.72	2.97	25.7	11.92	9.18	8.92
Price/Cash Flow	- -	- -	-15.16	-31.46	-23.78	-13.51	-13.78	15.8	-20.99	-5.2	-12.79	-28.47
Price/Cash Flow Average	- -	- -	-14.95	-25.41	-15.95	-18.53	-13.67	11.1	-19.06	-7.2	-7.55	-30.77
Price/Cash Flow High	- -	- -	-21.4	-42.99	-29.01	-27.32	-17.72	17.7	-23.09	-13.09	-13.03	-39.79
Price/Cash Flow Low	- -	- -	-10.36	-14.62	-8.77	-11.17	-8.31	6.1	-15.49	-4.84	-5.24	-23.58
Price/Free Cash Flow Average	- -	- -	-17.67	-28.11	-18.32	-19.98	-14.4	11.34	-152.18	-7.33	-7.84	-31.53
Price/Free Cash Flow High	- -	- -	-25.3	-47.55	-33.32	-29.46	-18.66	18.08	-184.35	-13.33	-13.53	-40.77
Price/Free Cash Flow Low	- -	- -	-12.25	-16.18	-10.08	-12.05	-8.75	6.23	-123.69	-4.93	-5.44	-24.16
EV/Sales Average	- -	- -	28.24	20.82	71.36	71.65	56.89	4.66	31.07	18.32	14.27	12.37
EV/Sales High	- -	- -	46.18	36.34	144.43	106.2	73.78	7.88	37.75	32.82	23.87	15.78
EV/Sales Low	- -	- -	15.51	11.3	31.24	42.72	34.45	2.22	25.15	12.52	10.23	9.65
EV/EBITDA Average	-1.99	-1.96	-6.35	-8.15	-10.22	-13.14	-10.63	11.73	-8.91	-7.23	-7.57	-32.15
EV/EBITDA High	-1.99	-1.96	-10.38	-14.21	-20.68	-19.47	-13.78	19.84	-10.83	-12.96	-12.66	-41.02
EV/EBITDA Low	-1.99	-1.96	-3.49	-4.42	-4.47	-7.83	-6.44	5.6	-7.21	-4.94	-5.42	-25.07
EV/EBIT Average	-1.94	-1.93	-6.23	-7.97	-10.11	-12.91	-10.47	11.98	-8.82	-7.07	-7.38	-29.68
EV/EBIT High	-1.94	-1.93	-10.19	-13.9	-20.46	-19.14	-13.58	20.26	-10.72	-12.67	-12.35	-37.87
EV/EBIT Low	-1.94	-1.93	-3.42	-4.32	-4.43	-7.7	-6.34	5.72	-7.14	-4.83	-5.29	-23.15
Last Price	- -	- -	26.34	28.05	75.41	53.91	80.11	112.15	107.11	43.81	92.24	87.22
High Price	- -	- -	37.17	38.33	92	109	102.98	125.61	117.86	110.23	94	121.9
Enterprise Value Average	41	77	322	578	1,529	3,190	3,784	3,700	5,595	3,738	3,559	6,293
Enterprise Value High	41	77	526	1,009	3,095	4,728	4,907	6,255	6,798	6,697	5,954	8,029
Enterprise Value Low	41	77	177	314	669	1,902	2,291	1,766	4,529	2,555	2,552	4,908

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	25	25	27	33	44	44	49	58	59	60	61	64
Diluted Weighted Avg Shares	13	13	18	27	38	44	48	56	59	60	61	63
Basic Weighted Avg Shares	13	13	18	27	38	44	48	55	59	60	61	63
Revenue per Share	- -	- -	0.63	1.01	0.57	1.01	1.39	14.55	3.08	3.42	4.12	8.09
EBITDA per Share	-1.57	-2.99	-2.78	-2.58	-3.96	-5.53	-7.44	5.78	-10.73	-8.67	-7.77	-3.11
Operating Income per Share	-1.61	-3.04	-2.83	-2.64	-4	-5.63	-7.55	5.66	-10.84	-8.86	-7.96	-3.37
Basic EPS, GAAP	-1.82	-3.52	-3.07	-2.64	-3.92	-5.39	-7.27	5.76	-11.01	-9.35	-8.37	-1.07
Basic EPS from Cont Ops	-1.6	-3.08	-2.89	-2.64	-3.92	-5.39	-7.27	5.76	-11.01	-9.35	-8.37	-1.07
Diluted EPS, GAAP	-1.82	-3.52	-3.07	-2.64	-3.92	-5.39	-7.27	5.59	-11.01	-9.35	-8.37	-1.07
Diluted EPS from Cont Ops	-1.6	-3.08	-2.89	-2.64	-3.92	-5.39	-7.27	5.59	-11.01	-9.35	-8.37	-1.07
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.45	-2.71	-1.74	-0.89	-3.17	-3.99	-5.81	7.1	-5.1	-8.42	-7.21	-3.06
Free Cash Flow per Basic Share	-1.47	-2.76	-2	-0.98	-3.58	-4.28	-6.11	7.04	-9.57	-8.57	-7.48	-3.14
Cash & Equivalents per Share	0.15	3.61	8.92	7.79	17.82	11.26	10.11	15.99	8.15	15.84	11.73	9.79
Book Value per Share	-3.2	-6.28	-7.4	-7.55	-9.41	-13.62	-19.76	-11.58	-21.79	-30.73	-38.64	-38.29
Tangible Book Value per Share	-3.17	-6.07	7.9	7.75	16.51	9.55	9.71	26.96	16.59	8.63	2.16	4.75

Blueprint Medicines Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)